Scorpius Holdings Inc - Company Profile

Powered by

All the sales intelligence you need on Scorpius Holdings Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Scorpius Holdings Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Scorpius Holdings Inc.

Back to companies

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

View up-to-date information on Scorpius Holdings Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
EP4034563A4 Search Report Tnfrsf25-vermittelte behandlungen von immunkrankheiten und störungen A61K2039/505; A61K2039/55; A61K2039/577; A61K35/17; A61K35/39; A61K38/2013; A61K38/28; A61K39/3955; A61P3/10; A61P37/06; A61P41/00; C07K16/2878; C07K2317/21; C07K2317/24; C07K2317/565; C07K2317/567; C07K2317/75 November 08, 2023
US20230303659A1 Application Intratumoral vaccination C12N2710/20043; A61K2039/572; A61K2039/585; A61K2039/70; A61K39/001176; A61K39/39; A61K41/0047; A61K9/0019; A61P35/00; C07K14/47; C07K14/70575; C07K2319/00; C07K2319/30 September 28, 2023
JP2023112132A Application Compositions and methods for adjoining type i and type ii extracellular domains as heterologous chimeric proteins C12N15/85; C12N7/00; A61K38/00; A61K38/177; A61K38/1774; A61K38/191; A61P35/00; A61P37/02; A61P37/04; A61P37/06; C07K14/00; C07K14/525; C07K14/70596; C07K19/00; C07K2319/00; C07K2319/74; Y02A50/30 August 10, 2023
IL303586A Application Compositions and methods for adjoining type i and type ii extracellular domains as heterologous chimeric proteins A61P37/04; A61K38/177; A61P37/02; A61K38/00; A61P35/00; C12N15/85; C07K14/525; C07K14/00; A61K38/1774; Y02A50/30; C07K2319/00; C07K2319/74; C07K14/70596; A61K38/191; C07K19/00; C12N7/00; A61P37/06 August 01, 2023
EP4183451A1 Application Zusammensetzungen und verfahren zum angrenzen von typ i und typ ii extrazellularen domänen als heterologe chimäre proteine C07K14/525; C07K14/00; C12N7/00; A61K38/191; A61P35/00; C07K14/70596; C07K2319/00; C07K2319/74; A61P37/04; C07K19/00; A61K38/00; Y02A50/30; A61K38/177; A61K38/1774; A61P37/06; C12N15/85; A61P37/02 May 24, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer